X-106928690-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020384.4(CLDN2):ā€‹c.462C>Gā€‹(p.Asp154Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,097,687 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 23)
Exomes š‘“: 0.0000018 ( 0 hom. 0 hem. )

Consequence

CLDN2
NM_020384.4 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.782
Variant links:
Genes affected
CLDN2 (HGNC:2041): (claudin 2) This gene product belongs to the claudin protein family whose members have been identified as major integral membrane proteins localized exclusively at tight junctions. Claudins are expressed in an organ-specific manner and regulate tissue-specific physiologic properties of tight junctions. This protein is expressed in the intestine. Alternatively spliced transcript variants with different 5' untranslated region have been found for this gene.[provided by RefSeq, Jan 2010]
MORC4 (HGNC:23485): (MORC family CW-type zinc finger 4) In human, the four current members of the microrchidia (morc) gene family share an N-terminal ATPase-like ATP-binding region and a CW four-cysteine zinc-finger motif. The protein encoded by this gene also has a nuclear matrix binding domain and a two-stranded coiled-coil motif near its C-terminus. This gene is widely expressed at low levels in normal tissues and has elevated expression in placenta and testis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10283601).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CLDN2NM_020384.4 linkuse as main transcriptc.462C>G p.Asp154Glu missense_variant 2/2 ENST00000336803.2 NP_065117.1
CLDN2NM_001171092.1 linkuse as main transcriptc.462C>G p.Asp154Glu missense_variant 2/2 NP_001164563.1
CLDN2NM_001171095.2 linkuse as main transcriptc.462C>G p.Asp154Glu missense_variant 2/2 NP_001164566.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CLDN2ENST00000336803.2 linkuse as main transcriptc.462C>G p.Asp154Glu missense_variant 2/22 NM_020384.4 ENSP00000336571 P1
CLDN2ENST00000540876.1 linkuse as main transcriptc.462C>G p.Asp154Glu missense_variant 2/21 ENSP00000443230 P1
CLDN2ENST00000541806.6 linkuse as main transcriptc.462C>G p.Asp154Glu missense_variant 2/21 ENSP00000441283 P1
MORC4ENST00000604604.1 linkuse as main transcriptc.111+64540G>C intron_variant 2 ENSP00000474750

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1097687
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
363051
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000119
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
Cov.:
23
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 30, 2024The c.462C>G (p.D154E) alteration is located in exon 2 (coding exon 1) of the CLDN2 gene. This alteration results from a C to G substitution at nucleotide position 462, causing the aspartic acid (D) at amino acid position 154 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
16
DANN
Benign
0.95
DEOGEN2
Benign
0.34
T;T;T
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.61
T;.;.
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.10
T;T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.38
N;N;N
MutationTaster
Benign
0.91
D;D;D
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.46
N;N;N
REVEL
Benign
0.20
Sift
Benign
0.46
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.018
B;B;B
Vest4
0.069
MutPred
0.20
Loss of ubiquitination at K157 (P = 0.1113);Loss of ubiquitination at K157 (P = 0.1113);Loss of ubiquitination at K157 (P = 0.1113);
MVP
0.54
MPC
0.51
ClinPred
0.13
T
GERP RS
2.3
Varity_R
0.074
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140513089; hg19: chrX-106171920; API